This is quantitatively supported by the p -value of less than 0.0001, indicating a highly significant difference between the survival outcomes of the two groups.
← all excerpts
Optimizing Glioblastoma, IDH-wildtype Treatment Outcomes : A Radiomics and Support Vector Machine-Based Approach to Overall Survival Estimation.
1
—
—